Abstract
HaemophiliaVolume 27, Issue 3 p. e409-e411 LETTER TO THE EDITOR Characterization of a plasma-derived double−viral-inactivated factor VIII concentrate (antihaemophilic factor [human]): Focus on TTP treatment Filippo Mori, Filippo Mori orcid.org/0000-0001-8940-5415 Department of Research & Innovation, Kedrion S.p.A, Loc. Bolognana, ItalySearch for more papers by this authorIlaria Nardini, Ilaria Nardini Department of Research & Innovation, Kedrion S.p.A, Loc. Bolognana, ItalySearch for more papers by this authorAndrea Caricasole, Andrea Caricasole Department of Research & Innovation, Kedrion S.p.A, Loc. Bolognana, ItalySearch for more papers by this authorNovinyo Serge Amega, Novinyo Serge Amega Department of Medical Affairs, Kedrion Biopharma Inc, Fort Lee, New Jersey, USASearch for more papers by this authorClaudio Farina, Claudio Farina Department of Research & Innovation, Kedrion S.p.A, Loc. Bolognana, ItalySearch for more papers by this author Filippo Mori, Filippo Mori orcid.org/0000-0001-8940-5415 Department of Research & Innovation, Kedrion S.p.A, Loc. Bolognana, ItalySearch for more papers by this authorIlaria Nardini, Ilaria Nardini Department of Research & Innovation, Kedrion S.p.A, Loc. Bolognana, ItalySearch for more papers by this authorAndrea Caricasole, Andrea Caricasole Department of Research & Innovation, Kedrion S.p.A, Loc. Bolognana, ItalySearch for more papers by this authorNovinyo Serge Amega, Novinyo Serge Amega Department of Medical Affairs, Kedrion Biopharma Inc, Fort Lee, New Jersey, USASearch for more papers by this authorClaudio Farina, Claudio Farina Department of Research & Innovation, Kedrion S.p.A, Loc. Bolognana, ItalySearch for more papers by this author First published: 02 February 2021 https://doi.org/10.1111/hae.14260 Correspondence Filippo Mori, Department of Research & Innovation, Kedrion, Via di Fondovalle, Loc. Bolognana, Italy. Email: f.mori@kedrion.com Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article. Volume27, Issue3May 2021Pages e409-e411 RelatedInformation
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Haemophilia : the official journal of the World Federation of Hemophilia
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
